Category Business

FDA approves GSK RSV vaccine for adults 50 to 59

A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The Food and Drug Administration on Friday expanded the approval of GSK‘s respiratory syncytial virus vaccine to adults ages 50 to 59 who are at…

Beijing’s new world order

Just over 30 years since the cold war ended, commentators are struggling to describe a new era of great power competition, this time between China and the US-led west. The problem is that so much about this new era is…

Fed meeting and CPI report: Jim Cramer’s week ahead

CNBC’s Jim Cramer on Friday guided investors through next week’s most market-moving events, highlighting the Federal Reserve’s meeting and the latest consumer price index report. “I’d be careful making a big move before the Fed meeting. We can’t be sure…